Bakker, Emyr ORCID: 0000-0002-0091-1029, Fujii, Masayuki, Krstic‑Demonacos, Marija, Demonacos, Constantinos and Alhammad, Rashed
(2022)
Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies.
International Journal of Oncology, 60
(2).
ISSN 1019-6439
Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Demonacos, Constantinos, Giordano, Antonio, Krstic-Demonacos, Marija and Mutti, Luciano
(2019)
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.
International Journal of Molecular Sciences, 20
(2).
ISSN 1661-6596
Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Bonanni, Ezio, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano
(2019)
What can independent research for mesothelioma achieve to treat this orphan disease?
Expert Opinion on Investigational Drugs, 28
(8).
pp. 719-732.
ISSN 1354-3784
Tian, Kun, Bakker, Emyr ORCID: 0000-0002-0091-1029, Hussain, Michelle, Guazzelli, Alice, Alhebshi, Hasen, Meysami, Parisa, Demonacos, Constantinos, Schwartz, Jean-Marc, Mutti, Luciano et al
(2018)
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
Journal of Translational Medicine, 16
.
p. 282.
Bakker, Emyr ORCID: 0000-0002-0091-1029, Tian, Kun, Mutti, Luciano, Demonacos, Constantinos, Schwartz, Jean-Marc and Krstic-Demonacos, Marija
(2017)
Insight into glucocorticoid receptor signalling through interactome model analysis.
PLoS computational biology, 13
(11).
e1005825.
ISSN 1553-734X
Bakker, Emyr ORCID: 0000-0002-0091-1029, Guazzelli, Alice, Ashtiani, Firozeh, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano
(2017)
Immunotherapy advances for mesothelioma treatment.
Expert Review of Anticancer Therapy, 17
(9).
pp. 799-814.
ISSN 1473-7140
Guazzelli, Alice, Bakker, Emyr ORCID: 0000-0002-0091-1029, Tian, Kun, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano
(2017)
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Expert Opinion on Investigational Drugs, 26
(8).
pp. 933-944.
ISSN 1354-3784
Qattan, Malak Yahia, Bakker, Emyr ORCID: 0000-0002-0091-1029, Rajendran, Ramkumar, Chen, Daphne Wei-Chen, Saha, Vaskar, Liu, Jizhong, Zeef, Leo, Schwartz, Jean-Marc, Mutti, Luciano et al
(2017)
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia.
PloS one, 12
(6).
e0178606.
Bakker, Emyr ORCID: 0000-0002-0091-1029, Qattan, Malak, Mutti, Luciano, Demonacos, Constantinos and Krstic-Demonacos, Marija
(2015)
The role of microenvironment and immunity in drug response in leukemia.
BBA - Biochimica et Biophysica Acta, 1863
(3).
pp. 414-426.
ISSN 0006-3002